Spyre Therapeutics Prices Public Offering of 4.1M Shares at $85.00
Spyre Therapeutics has priced its previously announced underwritten public offering of 4.1 million shares of common stock at a price of $85.00 per share.
Spyre Therapeutics has priced its previously announced underwritten public offering of 4.1 million shares of common stock at a price of $85.00 per share.